Evicenter
MarkdownMedical informationP&T meetings
Rinzimetostat (ORIC-944)

Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide

Regulatory status
Not announced
Launch
Not announced
Last updated
165 sources

Product information and disease descriptionProduct descriptionProduct information

Co-prescribed/Concomitant therapies

8 evidence topics · 5 sources

Darolutamide: wholesale acquisition cost filing with the California Department of Health Care Access and Information
FieldQuoted record
Manufacturer name“Bayer”
National drug code“50419039501”
Drug product description“Nubeqa 300 mg tab 120 count”
WAC effective date“2026-01-01T00:00:00”
WAC increase amount (USD)“847.20”
WAC after increase (USD)“15100.80”